"Biopure summary" Essays and Research Papers

Sort By:
Satisfactory Essays
Good Essays
Better Essays
Powerful Essays
Best Essays
Page 1 of 50 - About 500 Essays
  • Satisfactory Essays

    Biopure

    • 386 Words
    • 2 Pages

    Biopure Overview: * Biopure Corporation is a privately owned biopharmaceutical firm specializing in the ultrapurification of proteins for human and veterinary use. * It is one of the three legitimate contenders in the emerging field of “blood substitutes”. * Their products Oxyglobin and Hemopure are blood substitutes for the animal and the human market respectively. * Oxyglobin has just received final FDA approval for commercial release and is ready for launch. Hemopure would soon

    Premium Blood Blood transfusion

    • 386 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Biopure Case Group1 SecB

    • 977 Words
    • 36 Pages

    Biopure  Case  Analysis                     Group  1‚  Section  B     The  analysis  deals  with  the  Target  Markets  and  their  different  segments  for  the  two  products  of   Biopure  Corporation‚  namely  Oxyglobin  and  Hemopure.     Oxyglobin   -­‐ Used  as  a  substitute  for  blood  transfusion  in  dogs.   -­‐ Target   market   is  30%   of   all   the

    Premium

    • 977 Words
    • 36 Pages
    Good Essays
  • Better Essays

    Q1. Should Biopure launch Oxyglobin? Why? Support your arguments with quantitative analysis (ie. calc. of market potential). We believe that Biopure should launch Oxyglobin now. First of all‚ the potential market demand is huge. While current annual demand is 354‚750 units (95% primary care practices x 17 units canine blood/primary care practice + 5% specialty care practices x 150 units canine blood/specialty care practice)i accounting for only 2.5% of the cases‚ potential market demand including

    Premium Blood Marketing Blood transfusion

    • 1310 Words
    • 6 Pages
    Better Essays
  • Satisfactory Essays

    Carl Rausch President and CEO of Biopure Corporation FROM: Hoang‚ Ann and Mishra‚ Ravi RE: Whether and When to Launch Oxyglobin Biopure needs to determine the best course of action to launch two new products‚ Oxyglobin a blood substitute for the veterinary market and Hemopure a blood substitute for the human market. Oxyglobin has been approved for commercial use and is ready for launch while Hemopure is expected to be FDA approved within two years. Biopure needs to decide whether and when

    Premium Blood Blood transfusion Marketing

    • 1016 Words
    • 5 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Biopure Hbs Summary

    • 325 Words
    • 2 Pages

    Andrew Walters 3/22/12 Biopure Biopure Corporation specializes in blood substitutes for transfusion patients‚ both in the veterinary market and the human market. However‚ in 1998‚ Biopure faced the monumental decision of whether to begin selling Oxyglobin‚ a blood substitute‚ to the veterinary market or to wait until Hemoglobin‚ a blood substitute for the human market‚ became available for sale. The problem is whether or not the company should launch Oxyglobin before Hemoglobin is FDA-approved

    Premium Blood transfusion Blood

    • 325 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    marketing

    • 494 Words
    • 2 Pages

    Background Biopure Corporation a company founded in 1984 with the primary goal of developing a human blood substitute; a product that has oxygen-carrying property of blood without the harmful effects of donated blood. The company currently has two new products: Oxyglobin and Hemopure. Oxyglobin‚ blood substitute for the veterinary market and is ready for launch. Hemopure‚ another blood substitute but for the human market and it will take two years to launch the product; provided they get FDA approval

    Premium Blood Pricing

    • 494 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Biopure Case Summary

    • 847 Words
    • 4 Pages

    oxygen requirements in a broad range of potential medical applications. The main issue that is plaguing Biopure is how the possible launch of Oxyglobin will affect the future launch and pricing strategies of Hemopure‚ which could provide a larger return for their investment. Biopure’s strength lies in their ability to market its blood substitute products for both human and animal use. Biopure has a product that has been approved by the FDA for animal use and has the intellectual property that will

    Premium Blood Marketing Blood transfusion

    • 847 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Biopure Case Summary

    • 1918 Words
    • 8 Pages

    in its ability to market its blood substitute technology for both animal and human use. Further‚ Biopure has the patents and FDA approval to forge ahead in the animal market with a two-to-five year time buffer from new competition (using similar technology). One of the company’s weaknesses is that it has not received FDA approval on Hemopure‚ and there are two other companies that could beat Biopure to the market with similar products. But if the FDA does not approve Hemopure‚ which could have

    Premium Blood Pharmacology Marketing

    • 1918 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    Oxyglobin Case

    • 621 Words
    • 3 Pages

    network would require a commission to the distributor of 20% to 30% of the selling price. At $200 and 300‚000 units‚ this would be between $9‚000‚000 and $13‚500‚000. It is more cost effective for Biopure to sell directly to the veterinary practices. This manufacturer direct model (Exhibit 4) will require Biopure to recruit and maintain a sales force of approximately 10 employees (at an estimate total cost of $100‚000 per) and carries a $10-$15 distribution cost per unit. With 750 emergency practices‚

    Premium Blood Price Marketing

    • 621 Words
    • 3 Pages
    Good Essays
  • Good Essays

    How best to exploit the opportunity presented by Oxyglobin without jeopardizing the potential of Hemopure is a tough problem for Biopure’s executive. According to the financial analysis‚ it is suggested that Biopure begin to sell Oxyglobin at $150 per unit to emergency care practice at the Veterinary Blood Market and have its own distribution network. This will make a profit of $5 million at first year and $17 million thereafter. The steadfast income will consolidate Biopure’s financial structure

    Premium Blood Marketing Economics

    • 616 Words
    • 3 Pages
    Good Essays
Previous
Page 1 2 3 4 5 6 7 8 9 50